Exclusion Criteria:~General~* Participation in another therapeutic clinical trial within 30 days before
Baseline~* Prior participation in an amyloid vaccination clinical study~* Inability to swallow capsules~*
Likely inability to complete 24 week study~* Inability to be â‰¥75% compliant with single-blind placebo run-in
medication~* Inability to adequately perform cognitive tests~* History of significant cardiovascular disease~*
Major depression~* Psychosis~* History of stroke within 18 months of screening~* Head trauma~* Inability to
perform any screening or baseline evaluations
